Mitigation of Postoperative Delirium in High-Risk Patients

ID#: NCT05777187

Age: 18 - 120 years

Gender: All

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: June 20, 2023

End Date: June 30, 2024

Contact Information:
Kerry R Meyers, MPH
646-901-9237
Rachelle Weisman, MPH
(332) 237-8978
Summary: Among patients with cognitive impairment (CI) that undergo surgery, the risk for developing postoperative delirium (POD) is high (50%) and associated with further morbidity and mortality. Yet, 30-40% of POD cases are preventable with perioperative management. This randomized pragmatic clinical trial aims to assess incidence of POD in adult surgical patients with CI, as well as provider adherence to a set of 12 perioperative best practice recommendations for perioperative management. Electronic health record (EHR) data will be used to identify patients as high risk for developing POD and clinical decision support (CDS) prompts within the EHR will display best practices. Cases will be randomized to either the control group, usual care or the intervention which includes the high-risk alert and best practice prompts.
Eligibility:

Inclusion Criteria:

- Adult patients with a history of cognitive impairment (CI) undergoing surgery at the Mount Sinai Health System.

- Attending physicians, resident physicians, and nurse anesthetists at the Mount Sinai Health System receiving CDS alerts during EHR system implementation.

Exclusion Criteria:

- Patients will be excluded if this not their first surgery since study start, if they do not have cognitive impairment based on EHR data, or if the surgery is for organ donation.

- There will be no exclusion criteria for providers or historical controls.
Find a Clinical Trial Find Cancer Clinical Trials